InvestorsHub Logo

ssc

Followers 40
Posts 14181
Boards Moderated 1
Alias Born 12/20/2006

ssc

Re: Hncher post# 5884

Monday, 07/10/2017 2:10:16 PM

Monday, July 10, 2017 2:10:16 PM

Post# of 9560
Good choice of words: "they still made off with $14M from CRS". Especially like "made off" akin to Madoff (Bernie)? And what's left of that $14M from CRS?

As of March 31, 2017 the Company has cumulative losses totaling $(60,087,000) and working capital of $740,000. The Company had a net loss, including its noncontrolling interest of Imagion Biosystems, Inc., of $1,654,000 for the three months ended March 31, 2017. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations.

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.



Regarding IBX, not long ago mhtx owned 50%, now down to 29% and IBX will need a lot more fund raising for human trials, IF they ever get that far. You're right, these guys are good, making a very comfortable living for years and years while investors have a 3 cent stock in a company with serious going concern issues.